ANXA5 and COVID-19: In ICU patients with COVID-19, we measured an increased percentage of procoagulant platelets (n = 17, 22.8 ± 16.1%), identified with the phosphatidylserine-binding protein Annexin V, compared to controls (n = 13, 8.7 ± 15.7%) (Figure 3D).